UniProt ID | TCPB_HUMAN | |
---|---|---|
UniProt AC | P78371 | |
Protein Name | T-complex protein 1 subunit beta | |
Gene Name | CCT2 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 535 | |
Subcellular Localization | Cytoplasm . | |
Protein Description | Molecular chaperone; assists the folding of proteins upon ATP hydrolysis. As part of the BBS/CCT complex may play a role in the assembly of BBSome, a complex involved in ciliogenesis regulating transports vesicles to the cilia. Known to play a role, in vitro, in the folding of actin and tubulin.. | |
Protein Sequence | MASLSLAPVNIFKAGADEERAETARLTSFIGAIAIGDLVKSTLGPKGMDKILLSSGRDASLMVTNDGATILKNIGVDNPAAKVLVDMSRVQDDEVGDGTTSVTVLAAELLREAESLIAKKIHPQTIIAGWREATKAAREALLSSAVDHGSDEVKFRQDLMNIAGTTLSSKLLTHHKDHFTKLAVEAVLRLKGSGNLEAIHIIKKLGGSLADSYLDEGFLLDKKIGVNQPKRIENAKILIANTGMDTDKIKIFGSRVRVDSTAKVAEIEHAEKEKMKEKVERILKHGINCFINRQLIYNYPEQLFGAAGVMAIEHADFAGVERLALVTGGEIASTFDHPELVKLGSCKLIEEVMIGEDKLIHFSGVALGEACTIVLRGATQQILDEAERSLHDALCVLAQTVKDSRTVYGGGCSEMLMAHAVTQLANRTPGKEAVAMESYAKALRMLPTIIADNAGYDSADLVAQLRAAHSEGNTTAGLDMREGTIGDMAILGITESFQVKRQVLLSAAEAAEVILRVDNIIKAAPRKRVPDHHPC | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
1 (in isoform 2) | Acetylation | - | 5.29 | 22814378 | |
2 | Acetylation | ------MASLSLAPV ------CCCCCCCCH | 21.12 | 20068231 | |
3 | Phosphorylation | -----MASLSLAPVN -----CCCCCCCCHH | 19.72 | 29255136 | |
5 | Phosphorylation | ---MASLSLAPVNIF ---CCCCCCCCHHEE | 21.71 | 29255136 | |
13 | Ubiquitination | LAPVNIFKAGADEER CCCHHEECCCCCHHH | 41.96 | 21890473 | |
13 | Ubiquitination | LAPVNIFKAGADEER CCCHHEECCCCCHHH | 41.96 | 21890473 | |
13 | Ubiquitination | LAPVNIFKAGADEER CCCHHEECCCCCHHH | 41.96 | 21890473 | |
13 | Ubiquitination | LAPVNIFKAGADEER CCCHHEECCCCCHHH | 41.96 | 21890473 | |
13 | Ubiquitination | LAPVNIFKAGADEER CCCHHEECCCCCHHH | 41.96 | 21890473 | |
13 | 2-Hydroxyisobutyrylation | LAPVNIFKAGADEER CCCHHEECCCCCHHH | 41.96 | - | |
13 | Acetylation | LAPVNIFKAGADEER CCCHHEECCCCCHHH | 41.96 | 19608861 | |
13 | Ubiquitination | LAPVNIFKAGADEER CCCHHEECCCCCHHH | 41.96 | 21890473 | |
13 (in isoform 2) | Phosphorylation | - | 41.96 | 29507054 | |
23 | Phosphorylation | ADEERAETARLTSFI CCHHHHHHHHHHHHH | 18.98 | - | |
27 | Phosphorylation | RAETARLTSFIGAIA HHHHHHHHHHHHHHH | 18.95 | 27273156 | |
28 | Phosphorylation | AETARLTSFIGAIAI HHHHHHHHHHHHHHH | 21.32 | 21601212 | |
40 | Ubiquitination | IAIGDLVKSTLGPKG HHHHHHHHHCCCCCC | 45.05 | 21906983 | |
46 | Ubiquitination | VKSTLGPKGMDKILL HHHCCCCCCCCEEEE | 66.13 | - | |
50 | Ubiquitination | LGPKGMDKILLSSGR CCCCCCCEEEECCCC | 26.76 | 21890473 | |
54 | Phosphorylation | GMDKILLSSGRDASL CCCEEEECCCCCCEE | 27.57 | 23403867 | |
55 | Phosphorylation | MDKILLSSGRDASLM CCEEEECCCCCCEEE | 37.50 | 23403867 | |
60 | Phosphorylation | LSSGRDASLMVTNDG ECCCCCCEEEEECCC | 22.68 | 30266825 | |
62 | Sulfoxidation | SGRDASLMVTNDGAT CCCCCEEEEECCCCH | 3.02 | 21406390 | |
64 | Phosphorylation | RDASLMVTNDGATIL CCCEEEEECCCCHHH | 17.39 | 30266825 | |
72 | Ubiquitination | NDGATILKNIGVDNP CCCCHHHHHCCCCCH | 42.54 | 21890473 | |
72 | Ubiquitination | NDGATILKNIGVDNP CCCCHHHHHCCCCCH | 42.54 | 21890473 | |
72 | Ubiquitination | NDGATILKNIGVDNP CCCCHHHHHCCCCCH | 42.54 | 21890473 | |
72 | Ubiquitination | NDGATILKNIGVDNP CCCCHHHHHCCCCCH | 42.54 | 21890473 | |
72 | Ubiquitination | NDGATILKNIGVDNP CCCCHHHHHCCCCCH | 42.54 | 21890473 | |
72 | Ubiquitination | NDGATILKNIGVDNP CCCCHHHHHCCCCCH | 42.54 | 21890473 | |
82 | Ubiquitination | GVDNPAAKVLVDMSR CCCCHHHEEEEEHHH | 37.90 | 21890473 | |
82 | Ubiquitination | GVDNPAAKVLVDMSR CCCCHHHEEEEEHHH | 37.90 | 21890473 | |
82 | Ubiquitination | GVDNPAAKVLVDMSR CCCCHHHEEEEEHHH | 37.90 | 21890473 | |
82 | Ubiquitination | GVDNPAAKVLVDMSR CCCCHHHEEEEEHHH | 37.90 | 21890473 | |
82 | Ubiquitination | GVDNPAAKVLVDMSR CCCCHHHEEEEEHHH | 37.90 | 21890473 | |
82 | Ubiquitination | GVDNPAAKVLVDMSR CCCCHHHEEEEEHHH | 37.90 | 21890473 | |
99 | Phosphorylation | DDEVGDGTTSVTVLA CCCCCCCHHHHHHHH | 22.19 | 30622161 | |
100 | Phosphorylation | DEVGDGTTSVTVLAA CCCCCCHHHHHHHHH | 27.08 | 30622161 | |
101 | Phosphorylation | EVGDGTTSVTVLAAE CCCCCHHHHHHHHHH | 18.67 | 30622161 | |
103 | Phosphorylation | GDGTTSVTVLAAELL CCCHHHHHHHHHHHH | 15.01 | 30622161 | |
107 | Acetylation | TSVTVLAAELLREAE HHHHHHHHHHHHHHH | 12.10 | 19608861 | |
107 | Ubiquitination | TSVTVLAAELLREAE HHHHHHHHHHHHHHH | 12.10 | 19608861 | |
115 | Phosphorylation | ELLREAESLIAKKIH HHHHHHHHHHHHHHC | 31.93 | 21815630 | |
119 | Acetylation | EAESLIAKKIHPQTI HHHHHHHHHHCHHHE | 45.31 | 25953088 | |
119 | Succinylation | EAESLIAKKIHPQTI HHHHHHHHHHCHHHE | 45.31 | 23954790 | |
119 | Ubiquitination | EAESLIAKKIHPQTI HHHHHHHHHHCHHHE | 45.31 | - | |
120 | Ubiquitination | AESLIAKKIHPQTII HHHHHHHHHCHHHEE | 36.91 | 21890473 | |
120 | Ubiquitination | AESLIAKKIHPQTII HHHHHHHHHCHHHEE | 36.91 | 21890473 | |
120 | Ubiquitination | AESLIAKKIHPQTII HHHHHHHHHCHHHEE | 36.91 | 21890473 | |
120 | Ubiquitination | AESLIAKKIHPQTII HHHHHHHHHCHHHEE | 36.91 | 21890473 | |
120 | Ubiquitination | AESLIAKKIHPQTII HHHHHHHHHCHHHEE | 36.91 | 21890473 | |
120 | Ubiquitination | AESLIAKKIHPQTII HHHHHHHHHCHHHEE | 36.91 | 21906983 | |
134 | Acetylation | IAGWREATKAAREAL ECCHHHHHHHHHHHH | 19.23 | 19608861 | |
134 | Phosphorylation | IAGWREATKAAREAL ECCHHHHHHHHHHHH | 19.23 | 22210691 | |
143 | Phosphorylation | AAREALLSSAVDHGS HHHHHHHHHHHHCCC | 19.66 | 20068231 | |
144 | Phosphorylation | AREALLSSAVDHGSD HHHHHHHHHHHCCCC | 32.08 | 20068231 | |
150 | Phosphorylation | SSAVDHGSDEVKFRQ HHHHHCCCCCHHHHH | 27.46 | 20068231 | |
154 | Ubiquitination | DHGSDEVKFRQDLMN HCCCCCHHHHHHHHH | 32.55 | 21890473 | |
154 | Ubiquitination | DHGSDEVKFRQDLMN HCCCCCHHHHHHHHH | 32.55 | 21890473 | |
154 | Ubiquitination | DHGSDEVKFRQDLMN HCCCCCHHHHHHHHH | 32.55 | 21890473 | |
154 | Ubiquitination | DHGSDEVKFRQDLMN HCCCCCHHHHHHHHH | 32.55 | 21890473 | |
154 | Ubiquitination | DHGSDEVKFRQDLMN HCCCCCHHHHHHHHH | 32.55 | 21890473 | |
154 | Acetylation | DHGSDEVKFRQDLMN HCCCCCHHHHHHHHH | 32.55 | 19608861 | |
154 | Malonylation | DHGSDEVKFRQDLMN HCCCCCHHHHHHHHH | 32.55 | 26320211 | |
154 | Ubiquitination | DHGSDEVKFRQDLMN HCCCCCHHHHHHHHH | 32.55 | 20639865 | |
160 | Sulfoxidation | VKFRQDLMNIAGTTL HHHHHHHHHHHCCCH | 4.60 | 21406390 | |
165 | Phosphorylation | DLMNIAGTTLSSKLL HHHHHHCCCHHHHHH | 18.62 | 23403867 | |
166 | Phosphorylation | LMNIAGTTLSSKLLT HHHHHCCCHHHHHHH | 24.59 | 23403867 | |
168 | Phosphorylation | NIAGTTLSSKLLTHH HHHCCCHHHHHHHCC | 24.28 | 23403867 | |
169 | Phosphorylation | IAGTTLSSKLLTHHK HHCCCHHHHHHHCCH | 30.36 | 21815630 | |
170 | 2-Hydroxyisobutyrylation | AGTTLSSKLLTHHKD HCCCHHHHHHHCCHH | 44.11 | - | |
170 | Acetylation | AGTTLSSKLLTHHKD HCCCHHHHHHHCCHH | 44.11 | 25953088 | |
170 | Ubiquitination | AGTTLSSKLLTHHKD HCCCHHHHHHHCCHH | 44.11 | - | |
176 | Acetylation | SKLLTHHKDHFTKLA HHHHHCCHHHHHHHH | 45.34 | 26051181 | |
176 | Ubiquitination | SKLLTHHKDHFTKLA HHHHHCCHHHHHHHH | 45.34 | - | |
181 | Acetylation | HHKDHFTKLAVEAVL CCHHHHHHHHHHHHH | 33.24 | 19608861 | |
191 | Ubiquitination | VEAVLRLKGSGNLEA HHHHHHHCCCCCHHH | 44.59 | 21890473 | |
191 | Ubiquitination | VEAVLRLKGSGNLEA HHHHHHHCCCCCHHH | 44.59 | 21890473 | |
191 | Ubiquitination | VEAVLRLKGSGNLEA HHHHHHHCCCCCHHH | 44.59 | 21890473 | |
191 | Ubiquitination | VEAVLRLKGSGNLEA HHHHHHHCCCCCHHH | 44.59 | 21890473 | |
191 | Ubiquitination | VEAVLRLKGSGNLEA HHHHHHHCCCCCHHH | 44.59 | 21890473 | |
191 | 2-Hydroxyisobutyrylation | VEAVLRLKGSGNLEA HHHHHHHCCCCCHHH | 44.59 | - | |
191 | Acetylation | VEAVLRLKGSGNLEA HHHHHHHCCCCCHHH | 44.59 | 23749302 | |
191 | Ubiquitination | VEAVLRLKGSGNLEA HHHHHHHCCCCCHHH | 44.59 | 21890473 | |
193 | Phosphorylation | AVLRLKGSGNLEAIH HHHHHCCCCCHHHHH | 23.95 | 23312004 | |
203 | Ubiquitination | LEAIHIIKKLGGSLA HHHHHHHHHHCCCCH | 41.14 | 21890473 | |
203 | Ubiquitination | LEAIHIIKKLGGSLA HHHHHHHHHHCCCCH | 41.14 | 21890473 | |
203 | Ubiquitination | LEAIHIIKKLGGSLA HHHHHHHHHHCCCCH | 41.14 | 21890473 | |
203 | Ubiquitination | LEAIHIIKKLGGSLA HHHHHHHHHHCCCCH | 41.14 | 21890473 | |
203 | Ubiquitination | LEAIHIIKKLGGSLA HHHHHHHHHHCCCCH | 41.14 | 21890473 | |
203 | 2-Hydroxyisobutyrylation | LEAIHIIKKLGGSLA HHHHHHHHHHCCCCH | 41.14 | - | |
203 | Acetylation | LEAIHIIKKLGGSLA HHHHHHHHHHCCCCH | 41.14 | 25953088 | |
203 | Ubiquitination | LEAIHIIKKLGGSLA HHHHHHHHHHCCCCH | 41.14 | 21890473 | |
204 | 2-Hydroxyisobutyrylation | EAIHIIKKLGGSLAD HHHHHHHHHCCCCHH | 41.79 | - | |
204 | Ubiquitination | EAIHIIKKLGGSLAD HHHHHHHHHCCCCHH | 41.79 | 21906983 | |
208 | Phosphorylation | IIKKLGGSLADSYLD HHHHHCCCCHHHHHC | 20.70 | 28152594 | |
212 | Phosphorylation | LGGSLADSYLDEGFL HCCCCHHHHHCCCCC | 23.22 | 28152594 | |
213 | Nitration | GGSLADSYLDEGFLL CCCCHHHHHCCCCCC | 20.79 | - | |
213 | Phosphorylation | GGSLADSYLDEGFLL CCCCHHHHHCCCCCC | 20.79 | 28152594 | |
222 | Acetylation | DEGFLLDKKIGVNQP CCCCCCCCCCCCCCC | 46.38 | 23236377 | |
222 | Ubiquitination | DEGFLLDKKIGVNQP CCCCCCCCCCCCCCC | 46.38 | 21906983 | |
223 | Sumoylation | EGFLLDKKIGVNQPK CCCCCCCCCCCCCCC | 44.34 | - | |
223 | 2-Hydroxyisobutyrylation | EGFLLDKKIGVNQPK CCCCCCCCCCCCCCC | 44.34 | - | |
223 | Sumoylation | EGFLLDKKIGVNQPK CCCCCCCCCCCCCCC | 44.34 | - | |
223 | Ubiquitination | EGFLLDKKIGVNQPK CCCCCCCCCCCCCCC | 44.34 | - | |
230 | Ubiquitination | KIGVNQPKRIENAKI CCCCCCCCHHHCCEE | 57.13 | - | |
236 | Ubiquitination | PKRIENAKILIANTG CCHHHCCEEEEECCC | 50.02 | 21890473 | |
236 | Ubiquitination | PKRIENAKILIANTG CCHHHCCEEEEECCC | 50.02 | 21890473 | |
236 | Ubiquitination | PKRIENAKILIANTG CCHHHCCEEEEECCC | 50.02 | 21890473 | |
236 | Ubiquitination | PKRIENAKILIANTG CCHHHCCEEEEECCC | 50.02 | 21890473 | |
236 | Ubiquitination | PKRIENAKILIANTG CCHHHCCEEEEECCC | 50.02 | 21890473 | |
236 | 2-Hydroxyisobutyrylation | PKRIENAKILIANTG CCHHHCCEEEEECCC | 50.02 | - | |
236 | Acetylation | PKRIENAKILIANTG CCHHHCCEEEEECCC | 50.02 | 25953088 | |
236 | Ubiquitination | PKRIENAKILIANTG CCHHHCCEEEEECCC | 50.02 | 21906983 | |
242 | Phosphorylation | AKILIANTGMDTDKI CEEEEECCCCCHHHE | 25.51 | 20860994 | |
244 | Sulfoxidation | ILIANTGMDTDKIKI EEEECCCCCHHHEEE | 4.76 | 21406390 | |
246 | Phosphorylation | IANTGMDTDKIKIFG EECCCCCHHHEEECC | 30.24 | 21815630 | |
248 | Ubiquitination | NTGMDTDKIKIFGSR CCCCCHHHEEECCCC | 48.25 | 21890473 | |
248 | Ubiquitination | NTGMDTDKIKIFGSR CCCCCHHHEEECCCC | 48.25 | 21890473 | |
248 | Ubiquitination | NTGMDTDKIKIFGSR CCCCCHHHEEECCCC | 48.25 | 21890473 | |
248 | Ubiquitination | NTGMDTDKIKIFGSR CCCCCHHHEEECCCC | 48.25 | 21890473 | |
248 | Ubiquitination | NTGMDTDKIKIFGSR CCCCCHHHEEECCCC | 48.25 | 21890473 | |
248 | 2-Hydroxyisobutyrylation | NTGMDTDKIKIFGSR CCCCCHHHEEECCCC | 48.25 | - | |
248 | Acetylation | NTGMDTDKIKIFGSR CCCCCHHHEEECCCC | 48.25 | 23954790 | |
248 | Sumoylation | NTGMDTDKIKIFGSR CCCCCHHHEEECCCC | 48.25 | 28112733 | |
248 | Ubiquitination | NTGMDTDKIKIFGSR CCCCCHHHEEECCCC | 48.25 | 21906983 | |
250 | Ubiquitination | GMDTDKIKIFGSRVR CCCHHHEEECCCCEE | 37.41 | 21890473 | |
250 | Ubiquitination | GMDTDKIKIFGSRVR CCCHHHEEECCCCEE | 37.41 | 21890473 | |
250 | Ubiquitination | GMDTDKIKIFGSRVR CCCHHHEEECCCCEE | 37.41 | 21890473 | |
250 | Ubiquitination | GMDTDKIKIFGSRVR CCCHHHEEECCCCEE | 37.41 | 21890473 | |
250 | Ubiquitination | GMDTDKIKIFGSRVR CCCHHHEEECCCCEE | 37.41 | 21890473 | |
250 | Ubiquitination | GMDTDKIKIFGSRVR CCCHHHEEECCCCEE | 37.41 | 21906983 | |
254 | Phosphorylation | DKIKIFGSRVRVDST HHEEECCCCEEECCC | 19.49 | 25056879 | |
260 | Phosphorylation | GSRVRVDSTAKVAEI CCCEEECCCCHHHHH | 27.66 | 27273156 | |
261 | Phosphorylation | SRVRVDSTAKVAEIE CCEEECCCCHHHHHH | 26.49 | 28176443 | |
263 | 2-Hydroxyisobutyrylation | VRVDSTAKVAEIEHA EEECCCCHHHHHHHH | 41.91 | - | |
263 | Ubiquitination | VRVDSTAKVAEIEHA EEECCCCHHHHHHHH | 41.91 | 21906983 | |
272 | Acetylation | AEIEHAEKEKMKEKV HHHHHHHHHHHHHHH | 64.52 | 23749302 | |
272 | Succinylation | AEIEHAEKEKMKEKV HHHHHHHHHHHHHHH | 64.52 | 23954790 | |
272 | Ubiquitination | AEIEHAEKEKMKEKV HHHHHHHHHHHHHHH | 64.52 | - | |
274 | Ubiquitination | IEHAEKEKMKEKVER HHHHHHHHHHHHHHH | 67.36 | - | |
278 | Ubiquitination | EKEKMKEKVERILKH HHHHHHHHHHHHHHH | 43.83 | - | |
284 | Ubiquitination | EKVERILKHGINCFI HHHHHHHHHCCCCEE | 37.10 | 21890473 | |
284 | Ubiquitination | EKVERILKHGINCFI HHHHHHHHHCCCCEE | 37.10 | 21890473 | |
284 | Ubiquitination | EKVERILKHGINCFI HHHHHHHHHCCCCEE | 37.10 | 21890473 | |
284 | Ubiquitination | EKVERILKHGINCFI HHHHHHHHHCCCCEE | 37.10 | 21890473 | |
284 | Ubiquitination | EKVERILKHGINCFI HHHHHHHHHCCCCEE | 37.10 | 21890473 | |
284 | Acetylation | EKVERILKHGINCFI HHHHHHHHHCCCCEE | 37.10 | 25953088 | |
284 | Methylation | EKVERILKHGINCFI HHHHHHHHHCCCCEE | 37.10 | - | |
284 | Ubiquitination | EKVERILKHGINCFI HHHHHHHHHCCCCEE | 37.10 | 21906983 | |
297 | Phosphorylation | FINRQLIYNYPEQLF EECCHHHHCCHHHHH | 19.75 | 22817900 | |
342 | 2-Hydroxyisobutyrylation | FDHPELVKLGSCKLI CCCHHHHCCCCCCEE | 60.81 | - | |
342 | Acetylation | FDHPELVKLGSCKLI CCCHHHHCCCCCCEE | 60.81 | 25953088 | |
342 | Ubiquitination | FDHPELVKLGSCKLI CCCHHHHCCCCCCEE | 60.81 | 21906983 | |
347 | Ubiquitination | LVKLGSCKLIEEVMI HHCCCCCCEEEEEEE | 54.95 | - | |
353 | Sulfoxidation | CKLIEEVMIGEDKLI CCEEEEEEECCCCEE | 3.54 | 21406390 | |
379 | Phosphorylation | TIVLRGATQQILDEA HHHHCHHHHHHHHHH | 24.67 | 21406692 | |
389 | Phosphorylation | ILDEAERSLHDALCV HHHHHHHHHHHHHHH | 22.89 | 28450419 | |
395 | Glutathionylation | RSLHDALCVLAQTVK HHHHHHHHHHHHHHC | 2.24 | 22555962 | |
395 | S-palmitoylation | RSLHDALCVLAQTVK HHHHHHHHHHHHHHC | 2.24 | 29575903 | |
402 | Acetylation | CVLAQTVKDSRTVYG HHHHHHHCCCCCEEC | 54.06 | 25953088 | |
402 | Ubiquitination | CVLAQTVKDSRTVYG HHHHHHHCCCCCEEC | 54.06 | 21906983 | |
404 | Phosphorylation | LAQTVKDSRTVYGGG HHHHHCCCCCEECCC | 24.92 | 22210691 | |
406 | Phosphorylation | QTVKDSRTVYGGGCS HHHCCCCCEECCCHH | 23.25 | 23403867 | |
408 | Phosphorylation | VKDSRTVYGGGCSEM HCCCCCEECCCHHHH | 14.94 | 22210691 | |
413 | Phosphorylation | TVYGGGCSEMLMAHA CEECCCHHHHHHHHH | 29.34 | 22210691 | |
415 | Sulfoxidation | YGGGCSEMLMAHAVT ECCCHHHHHHHHHHH | 1.46 | 30846556 | |
417 | Sulfoxidation | GGCSEMLMAHAVTQL CCHHHHHHHHHHHHH | 2.19 | 30846556 | |
422 | Phosphorylation | MLMAHAVTQLANRTP HHHHHHHHHHHHCCC | 20.74 | 25627689 | |
427 | Methylation | AVTQLANRTPGKEAV HHHHHHHCCCCCHHH | 36.37 | - | |
428 | Phosphorylation | VTQLANRTPGKEAVA HHHHHHCCCCCHHHH | 35.88 | 25159151 | |
431 | Acetylation | LANRTPGKEAVAMES HHHCCCCCHHHHHHH | 43.64 | 26051181 | |
431 | Ubiquitination | LANRTPGKEAVAMES HHHCCCCCHHHHHHH | 43.64 | 21906983 | |
436 | Sulfoxidation | PGKEAVAMESYAKAL CCCHHHHHHHHHHHH | 2.56 | 30846556 | |
438 | Phosphorylation | KEAVAMESYAKALRM CHHHHHHHHHHHHHH | 19.80 | 21712546 | |
439 | Phosphorylation | EAVAMESYAKALRML HHHHHHHHHHHHHHH | 9.98 | 23403867 | |
441 | Ubiquitination | VAMESYAKALRMLPT HHHHHHHHHHHHHCH | 39.46 | 21890473 | |
441 | Ubiquitination | VAMESYAKALRMLPT HHHHHHHHHHHHHCH | 39.46 | 21890473 | |
441 | Ubiquitination | VAMESYAKALRMLPT HHHHHHHHHHHHHCH | 39.46 | 21890473 | |
441 | Ubiquitination | VAMESYAKALRMLPT HHHHHHHHHHHHHCH | 39.46 | 21890473 | |
441 | Ubiquitination | VAMESYAKALRMLPT HHHHHHHHHHHHHCH | 39.46 | 21890473 | |
441 | 2-Hydroxyisobutyrylation | VAMESYAKALRMLPT HHHHHHHHHHHHHCH | 39.46 | - | |
441 | Acetylation | VAMESYAKALRMLPT HHHHHHHHHHHHHCH | 39.46 | 25953088 | |
441 | Ubiquitination | VAMESYAKALRMLPT HHHHHHHHHHHHHCH | 39.46 | 21890473 | |
445 | Sulfoxidation | SYAKALRMLPTIIAD HHHHHHHHHCHHHHC | 5.67 | 30846556 | |
448 | Phosphorylation | KALRMLPTIIADNAG HHHHHHCHHHHCCCC | 22.51 | - | |
456 | Phosphorylation | IIADNAGYDSADLVA HHHCCCCCCHHHHHH | 12.33 | - | |
458 | Phosphorylation | ADNAGYDSADLVAQL HCCCCCCHHHHHHHH | 18.39 | - | |
470 | Phosphorylation | AQLRAAHSEGNTTAG HHHHHHHHCCCCCCC | 42.33 | 28985074 | |
480 | Sulfoxidation | NTTAGLDMREGTIGD CCCCCCCCCCCCHHH | 5.16 | 21406390 | |
500 | Ubiquitination | ITESFQVKRQVLLSA CCCCHHHHHHHHHHH | 26.74 | - | |
522 | Ubiquitination | LRVDNIIKAAPRKRV HCHHHHHHHCCCCCC | 34.40 | 21890473 | |
522 | Ubiquitination | LRVDNIIKAAPRKRV HCHHHHHHHCCCCCC | 34.40 | 21890473 | |
522 | Ubiquitination | LRVDNIIKAAPRKRV HCHHHHHHHCCCCCC | 34.40 | 21890473 | |
522 | Ubiquitination | LRVDNIIKAAPRKRV HCHHHHHHHCCCCCC | 34.40 | 21890473 | |
522 | Ubiquitination | LRVDNIIKAAPRKRV HCHHHHHHHCCCCCC | 34.40 | 21890473 | |
522 | Acetylation | LRVDNIIKAAPRKRV HCHHHHHHHCCCCCC | 34.40 | 25953088 | |
522 | Ubiquitination | LRVDNIIKAAPRKRV HCHHHHHHHCCCCCC | 34.40 | 21890473 | |
527 | Ubiquitination | IIKAAPRKRVPDHHP HHHHCCCCCCCCCCC | 57.60 | - |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
260 | S | Phosphorylation | Kinase | AKT1 | P31749 | PSP |
260 | S | Phosphorylation | Kinase | RPS6KA1 | Q15418 | GPS |
260 | S | Phosphorylation | Kinase | RPS6KB1 | P23443 | GPS |
260 | S | Phosphorylation | Kinase | RSK-SUBFAMILY | - | GPS |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of TCPB_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of TCPB_HUMAN !! |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Acetylation | |
Reference | PubMed |
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, AND MASS SPECTROMETRY. | |
"Lysine acetylation targets protein complexes and co-regulates majorcellular functions."; Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.; Science 325:834-840(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-13; LYS-154 AND LYS-181, ANDMASS SPECTROMETRY. |